Human IgG4 kappa, Isotype Control

Human IgG4 kappa Isotype Control is a monoclonal antibody serving as an isotype control for the human IgG4κ antibody [1].

Human IgG4 (S228P) kappa, Isotype Control is a human-mouse chimeric antibody that can be used to study autoimmune diseases.

ENx-108A is a human IgG4 monoclonal antibody that targets IL-11. It is applicable for researching fibrotic diseases. Recommended isotype control: Human IgG4 kappa, Isotype Control.

IMP-761 is a human IgG4 monoclonal antibody (mAb) that targets CD223/LAG3. It binds to the D1 domain of human LAG32. The recommended isotype control is Human IgG4 kappa, Isotype Control.

CT140 is a human IgG4 monoclonal antibody (mAb) that specifically targets PAI-1. The suggested isotype control for this compound is Human IgG4 kappa, Isotype Control.

Anti-OX2R/CD200R1 Antibody is a human-derived antibody expressed in CHO cells and targets OX2R/CD200R1. The predicted molecular weight (MW) of Anti-OX2R/CD200R1 Antibody is 146.58 kDa. For the isotype control of Anti-OX2R/CD200R1 Antibody, refer to Human IgG4 kappa, Isotype Control.

Senlizumab is a human monoclonal antibody expressed in CHO cells that specifically targets TNFSF2 (Tumor Necrosis Factor-alpha, TNF-α). It features a huIgG4SP heavy chain and a huκ light chain, with a predicted molecular weight of 146.9 kDa. Senlizumab neutralizes the biological activity of TNF-α by blocking its interaction with TNF receptors, thereby inhibiting downstream pro-inflammatory signaling pathways. It serves as a valuable tool for research into autoimmune and inflammatory diseases. The recommended isotype control is Human IgG4 kappa, Isotype Control (HY-P99003).

Anti-PGLYRP1/PGRP-S Antibody is a CHO-expressed human antibody targeting PGLYRP1/PGRP-S. It features a huIgG4SP heavy chain and a huκ light chain, with an estimated molecular weight (MW) of 150 kDa. For isotype control, refer to Human IgG4 kappa, Isotype Control.

Nelmastobart is a human IgG4κ monoclonal antibody that targets BTN1A1. The isotype control product for Nelmastobart is Human IgG4(S228P) kappa, Isotype Control.

Vipalanebart is a human-derived IgG4κ monoclonal antibody targeting ADCYAP1R. Its isotype control product is HumanIgG4(S228P) kappa, Isotype Control.

Resugosbart is a human IgG4κ monoclonal antibody that antagonizes SOST. The isotype control for Resugosbart is Human IgG4(S228P) kappa, Isotype Control.

Vilamakitug is a human-derived IgG4κ monoclonal antibody that targets PDCD1. The isotype control product for Vilamakitug is HumanIgG4(S228P) kappa, Isotype Control.

Pamvatamig is a human IgG4κ monoclonal antibody that acts as an antagonist to EGFR/MET. The isotype control product for Pamvatamig is Human IgG4(S228P) kappa, Isotype Control.

Roconkibart is a human-derived IgG4κ monoclonal antibody that targets IL17A. Its isotype control product is HumanIgG4(S228P) kappa, Isotype Control.

Eltrekibart is a human IgG4κ monoclonal antibody that acts as an anti-CXCL agent. Its isotype control counterpart is Human IgG4 (S228P) kappa, Isotype Control.

Pradusinstobart is a human-derived IgG4κ monoclonal antibody targeting PDCD1. The isotype control for Pradusinstobart is HumanIgG4(S228P) kappa, Isotype Control.

Gruticibart is a human IgG4κ monoclonal antibody that targets F11. It has an isotype control product, Human IgG4(S228P) kappa, Isotype Control.

Negalstobart is a human-derived IgG4κ monoclonal antibody that targets LAG3. The isotype control product for Negalstobart is HumanIgG4(S228P) kappa, Isotype Control.

Anti-CD200R1/OX2R Antibody (I-4P) is a human monoclonal antibody (mAb) targeting CD200R1/OX2R. It is utilized in the study of solid tumors. Recommended isotype control: Human IgG4 kappa, Isotype Control.

BIIB022 is a human IgG4 monoclonal antibody (mAb) targeting IGF1R/CD221. It inhibits the phosphorylation of IGF-1 and IGF-2-induced IGF-1R and its downstream substrates. BIIB022 is applicable for research in lung cancer, pancreatic cancer, and colon cancer. The recommended isotype control is Human IgG4 kappa, Isotype Control.

Zamristobart is a humanized IgG4κ antibody that targets LILRB1 (leukocyte immunoglobulin-like receptor B1) and exhibits both immune-stimulating and antitumor properties. The suggested isotype control is HumanIgG4(S228P) kappa, Isotype Control.

Liscastobart is a humanized antibody of the IgG4κ type, specifically targeting PDCD1/PD-1/CD279. The corresponding isotype control for this antibody is HumanIgG4kappa, Isotype Control.

Ebribafusp alfa is a chimeric IgG4κ antibody that targets CD3E, with its corresponding isotype control designated as Human IgG4(S228P) kappa, Isotype Control.

Mibavademab is a recombinant humanized monoclonal antibody expressed in Chinese Hamster Ovary (CHO) cells that specifically targets the leptin receptor (LEPR/CD295). Mibavademab is composed of a human IgG4SP hinge-stabilized heavy chain and a human kappa (huκ) light chain, possesses a predicted molecular weight of 145.58 kDa. Mibavademab can be used in studies about the treatment of congenital leptin deficiency.